Rheumatoid arthritis (RA) is currently diagnosed and treated when an individual presents with signs and symptoms of inflammatory arthritis (IA) as well as other features, such as autoantibodies and/or ...

Rheumatoid arthritis (RA) is an autoimmune disease that causes joint inflammation and destruction. 1 There is currently no cure – and although there are many treatments, their effectiveness varies ...

In a review published in the Rheumatology Advances in Practice journal, researchers analyzed data on the association between intestinal microbiome dysbiosis and rheumatoid arthritis (RA). Study: The ...

Rheumatoid arthritis is one of the most common immune-mediated diseases. Its primary manifestation is inflammatory arthritis characterized by symmetric, polyarticular pain and swelling, typically ...

The cytokine interleukin-6 is involved in the pathogenesis of rheumatoid arthritis. Olokizumab, a humanized monoclonal antibody targeting the interleukin-6 cytokine directly, is being tested for the ...

Researchers from OU identified a protein complex involved in the pathogenesis of rheumatoid arthritis. They also show that celastrol, the active compound of a medicinal herb, blocks the progression of ...

The generation of anti-citrullinated protein autoantibodies (ACPA) are known key drivers in the pathogenesis of rheumatoid arthritis (RA) and are generated by peptidyl arginine deiminases (PADs), ...

Advances in RA treatment require improved understanding of patient-specific therapy appropriateness, focusing on disease pathogenesis and heterogeneity. Current RA treatment algorithms lack biomarkers ...

Women in the study were 3 times more likely to be affected by rheumatoid arthritis (RA) and nearly 4 times more likely to develop hypothyroidism, compared with men. A study published in Medicine found ...